Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.

Autor:	Clamp, Andrew R1 (AUTHOR), James, Elizabeth C1,2 (AUTHOR) E.james@ucl.ac.uk, McNeish, Iain A3 (AUTHOR), Dean, Andrew4 (AUTHOR), Kim, Jae-Won5 (AUTHOR), O'Donnell, Dearbhaile M6 (AUTHOR), Gallardo-Rincon, Dolores7 (AUTHOR), Blagden, Sarah8 (AUTHOR), Brenton, James9 (AUTHOR), Perren, Tim J10 (AUTHOR), Sundar, Sudha11 (AUTHOR), Lord, Rosemary12 (AUTHOR), Dark, Graham13 (AUTHOR), Hall, Marcia14 (AUTHOR), Banerjee, Susana15 (AUTHOR), Glasspool, Rosalind M16 (AUTHOR), Hanna, C Louise17 (AUTHOR), Williams, Sarah18 (AUTHOR), Scatchard, Kate M19,20 (AUTHOR), Nam, Helena21,22 (AUTHOR)
Zdroj:	Lancet Oncology. Jul2022, Vol. 23 Issue 7, p919-930. 12p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu